Cargando…

Biological markers in Helicobacter pylori-associated gastritis and carcinoma: the value of a scoring system

BACKGROUND: Helicobacter pylori-associated gastritis has been linked to the pathogenesis of gastric adenocarcinoma (GA), especially when associated with intestinal metaplasia (IM) and atypia/dysplasia (A/D). We examined p53 expression, ploidy and proliferative activity and assessed H. pylori infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mourad, Walid A., El Husseiny, Gamal, Shoukri, Mohamed, Rezeig, Mohamed, Chianzantoniou, Nikolaus, Amin, Tarek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147907/
https://www.ncbi.nlm.nih.gov/pubmed/15323272
http://dx.doi.org/10.5144/0256-4947.2004.112
_version_ 1783356654300954624
author Mourad, Walid A.
El Husseiny, Gamal
Shoukri, Mohamed
Rezeig, Mohamed
Chianzantoniou, Nikolaus
Amin, Tarek
author_facet Mourad, Walid A.
El Husseiny, Gamal
Shoukri, Mohamed
Rezeig, Mohamed
Chianzantoniou, Nikolaus
Amin, Tarek
author_sort Mourad, Walid A.
collection PubMed
description BACKGROUND: Helicobacter pylori-associated gastritis has been linked to the pathogenesis of gastric adenocarcinoma (GA), especially when associated with intestinal metaplasia (IM) and atypia/dysplasia (A/D). We examined p53 expression, ploidy and proliferative activity and assessed H. pylori infection in relationship to IM and/or A/D in cases of gastritis not associated with GA and in cases of GA. METHODS: We examined 53 gastric biopsies from patients with gastritis not associated with GA, including patients with gastritis not associated with IM and/or A/D (n=35) and with gastritis associated with IM and/or A/D (n=21). Thirty-six distal gastrectomy specimens from patients with GA constituted a third group of patients. A scoring system that encompassed the presence or absence of H. pylori, degree of gastritis, IM and/or A/D, p53, MIB-1 proliferative index (MPI) and ploidy was estimated in the cases of gastritis and in cancer-associated mucosa (CAM) and the adenocarcinoma from patients with GA. RESULTS: Patients with GA had a higher median age than those with gastritis without IM and more were males (ratio, 2.2:1). H. pylori was detected in 75% (40/53) of gastritis specimens and in 55% (20/36) of GA cases. There was a statistically significant difference between the incidence of gastritis without IM and/or A/D and CAM (P=0.01). p53 expression was seen in 67% of cases (14/21) of gastritis with IM and/or A/D and in only 5% (2 cases) of gastritis without IM (P=0.0005). A statistically significant difference in MPI was seen between CAM and GA (P=0.01) and gastritis without IM and/or A/D and gastritis with IM (P=0.004). Cases of gastritis without IM and/or A/D had a median score of 8 while cases of gastritis with IM and/or A/D had a median score of 12 (P=0.0003). CAM had a median score of 13, which was significantly different than gastritis without IM and/or A/D (P=0.0003). CONCLUSIONS: The presence of IM and/or A/D can be used in H. pylori-associated gastritis as a starting point to further investigate high-risk lesions. Those showing p53 expression, high proliferative activity and aneuploidy require closer follow up and perhaps additional biopsies. Although aneuploidy is commonly seen in GA, its presence in cases of gastritis as an isolated finding should not indicate a high-risk lesion.
format Online
Article
Text
id pubmed-6147907
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher King Faisal Specialist Hospital and Research Centre
record_format MEDLINE/PubMed
spelling pubmed-61479072018-09-21 Biological markers in Helicobacter pylori-associated gastritis and carcinoma: the value of a scoring system Mourad, Walid A. El Husseiny, Gamal Shoukri, Mohamed Rezeig, Mohamed Chianzantoniou, Nikolaus Amin, Tarek Ann Saudi Med Original Article BACKGROUND: Helicobacter pylori-associated gastritis has been linked to the pathogenesis of gastric adenocarcinoma (GA), especially when associated with intestinal metaplasia (IM) and atypia/dysplasia (A/D). We examined p53 expression, ploidy and proliferative activity and assessed H. pylori infection in relationship to IM and/or A/D in cases of gastritis not associated with GA and in cases of GA. METHODS: We examined 53 gastric biopsies from patients with gastritis not associated with GA, including patients with gastritis not associated with IM and/or A/D (n=35) and with gastritis associated with IM and/or A/D (n=21). Thirty-six distal gastrectomy specimens from patients with GA constituted a third group of patients. A scoring system that encompassed the presence or absence of H. pylori, degree of gastritis, IM and/or A/D, p53, MIB-1 proliferative index (MPI) and ploidy was estimated in the cases of gastritis and in cancer-associated mucosa (CAM) and the adenocarcinoma from patients with GA. RESULTS: Patients with GA had a higher median age than those with gastritis without IM and more were males (ratio, 2.2:1). H. pylori was detected in 75% (40/53) of gastritis specimens and in 55% (20/36) of GA cases. There was a statistically significant difference between the incidence of gastritis without IM and/or A/D and CAM (P=0.01). p53 expression was seen in 67% of cases (14/21) of gastritis with IM and/or A/D and in only 5% (2 cases) of gastritis without IM (P=0.0005). A statistically significant difference in MPI was seen between CAM and GA (P=0.01) and gastritis without IM and/or A/D and gastritis with IM (P=0.004). Cases of gastritis without IM and/or A/D had a median score of 8 while cases of gastritis with IM and/or A/D had a median score of 12 (P=0.0003). CAM had a median score of 13, which was significantly different than gastritis without IM and/or A/D (P=0.0003). CONCLUSIONS: The presence of IM and/or A/D can be used in H. pylori-associated gastritis as a starting point to further investigate high-risk lesions. Those showing p53 expression, high proliferative activity and aneuploidy require closer follow up and perhaps additional biopsies. Although aneuploidy is commonly seen in GA, its presence in cases of gastritis as an isolated finding should not indicate a high-risk lesion. King Faisal Specialist Hospital and Research Centre 2004 /pmc/articles/PMC6147907/ /pubmed/15323272 http://dx.doi.org/10.5144/0256-4947.2004.112 Text en Copyright © 2004, Annals of Saudi Medicine This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Mourad, Walid A.
El Husseiny, Gamal
Shoukri, Mohamed
Rezeig, Mohamed
Chianzantoniou, Nikolaus
Amin, Tarek
Biological markers in Helicobacter pylori-associated gastritis and carcinoma: the value of a scoring system
title Biological markers in Helicobacter pylori-associated gastritis and carcinoma: the value of a scoring system
title_full Biological markers in Helicobacter pylori-associated gastritis and carcinoma: the value of a scoring system
title_fullStr Biological markers in Helicobacter pylori-associated gastritis and carcinoma: the value of a scoring system
title_full_unstemmed Biological markers in Helicobacter pylori-associated gastritis and carcinoma: the value of a scoring system
title_short Biological markers in Helicobacter pylori-associated gastritis and carcinoma: the value of a scoring system
title_sort biological markers in helicobacter pylori-associated gastritis and carcinoma: the value of a scoring system
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147907/
https://www.ncbi.nlm.nih.gov/pubmed/15323272
http://dx.doi.org/10.5144/0256-4947.2004.112
work_keys_str_mv AT mouradwalida biologicalmarkersinhelicobacterpyloriassociatedgastritisandcarcinomathevalueofascoringsystem
AT elhusseinygamal biologicalmarkersinhelicobacterpyloriassociatedgastritisandcarcinomathevalueofascoringsystem
AT shoukrimohamed biologicalmarkersinhelicobacterpyloriassociatedgastritisandcarcinomathevalueofascoringsystem
AT rezeigmohamed biologicalmarkersinhelicobacterpyloriassociatedgastritisandcarcinomathevalueofascoringsystem
AT chianzantoniounikolaus biologicalmarkersinhelicobacterpyloriassociatedgastritisandcarcinomathevalueofascoringsystem
AT amintarek biologicalmarkersinhelicobacterpyloriassociatedgastritisandcarcinomathevalueofascoringsystem